Procter & Gamble Co., US7427181091

Procter & Gamble stock edges lower as investors weigh FY 2026 results and 3% dividend yield

Published on 09/07/2026 at 15:32 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS

Procter & Gamble stock trades around the mid-140 dollar range as investors digest modest fiscal 2026 growth, fresh FY 2027 guidance and a roughly 3% dividend yield backed by more than 70 years of consecutive payout increases.

Extremes Makrofoto von irisierenden Seifenblasen und weiĂźem Waschmittelschaum mit Regenbogenreflexen
Procter Kernkompetenz Reinigung US7427181091 in extremer Makro Aufnahme von schillernden irisierenden Seifenschaum Blasen, Illustration mit AI erstellt.

Procter & Gamble Company stock (ISIN US7427181091) is trading in the mid-140 dollar range as of September 7, 2026, with the latest snapshots putting the share price around USD 146.44 and showing a decline of roughly 0.33% versus the prior close, while the annual dividend yield stands near 3.0% according to data from The Motley Fool and MarketBeat as of early September 2026.

Dividend track record and FY 2026 performance

For income-oriented investors, the standout feature of Procter & Gamble is its exceptionally long dividend streak: the company has increased its annual dividend for 70 consecutive years, qualifying as a classic Dividend King and underpinning its appeal as a defensive consumer staples name, as highlighted by The Motley Fool on September 7, 2026.

In the most recently completed fiscal year 2026, Procter & Gamble generated more than USD 87 billion in revenue, which represents a 3% increase compared with fiscal year 2025, while earnings per share rose 2% to USD 6.62 over the same period, according to the overview cited by The Motley Fool. These figures show that top-line growth slightly outpaced bottom-line expansion, but both moved higher, giving the company room to sustain and gradually grow its dividend without overextending the payout.

Latest quarterly figures and FY 2027 guidance

Looking at the more near-term picture, Procter & Gamble last reported quarterly earnings on July 29, 2026, covering its latest fiscal quarter, where it delivered earnings per share of USD 1.43, beating the consensus estimate of USD 1.41 by USD 0.02, as summarized by MarketBeat. In that quarter, revenue reached USD 21.20 billion, compared with analyst expectations of USD 21.38 billion, and was up 1.5% year over year, while the prior-year quarter had produced EPS of USD 1.48, indicating that earnings per share slipped marginally even as sales expanded modestly.

The same earnings report showed that Procter & Gamble continued to post robust profitability metrics, with return on equity at 31.36% and a net margin of 18.44% for the latest quarter according to MarketBeat, underlining the company’s ability to convert revenue into solid earnings and cash flow despite a more challenging consumer environment. At the same time, management set fiscal year 2027 guidance for earnings per share in a range of USD 6.89 to USD 7.11, and equity analysts tracked by MarketBeat forecast EPS of about USD 6.99 for the current fiscal year, implying incremental growth versus the USD 6.62 recorded in fiscal year 2026.

Valuation, analyst targets and market positioning

On valuation, Procter & Gamble currently trades at a price-to-earnings ratio of around 22.10, with a price-to-earnings-growth (PEG) ratio of about 3.64 and a beta of 0.39, according to the latest snapshot from MarketBeat as of early September 2026. These metrics suggest that the stock is priced at a premium to the broader market relative to its expected growth, but offers lower volatility than many cyclical names, reinforcing its role as a defensive holding in diversified portfolios.

Analyst sentiment is broadly constructive but not euphoric: data compiled by MarketBeat indicate that thirteen investment analysts currently rate Procter & Gamble stock as a Buy and eleven as a Hold, yielding a consensus rating described as Moderate Buy with an average price target of USD 161.19 per share as of September 7, 2026. Relative to the latest trading level around USD 146, this consensus target implies upside of roughly 10% in addition to the 3.0% annual dividend yield, although individual ratings vary, with some firms such as Argus having downgraded the shares from Buy to Hold in August 2026.

Balance sheet strength and credit view

From a balance sheet perspective, Procter & Gamble enters this phase with moderate leverage and ample liquidity. The company’s debt-to-equity ratio stands at about 0.43, while its quick ratio is 0.47 and its current ratio is 0.68, according to the financial snapshot provided by MarketBeat. These figures point to a capital structure that uses debt but remains far from highly leveraged territory, and to working capital that is tight but manageable for a large, cash-generative consumer goods group.

Supporting this view, credit rating agency Moody’s recently raised Procter & Gamble’s credit outlook to positive, citing sustainable free cash flow and earnings growth alongside a strong balance sheet, as reported by The Motley Fool. For shareholders, a positive credit outlook can translate into lower financing costs and additional flexibility for shareholder returns, including dividends and potential buybacks, though the company’s priority remains maintaining and gradually increasing its cash payout.

Dividend, payout ratio and investor income

In the latest dividend cycle, Procter & Gamble paid a quarterly dividend of USD 1.0885 per share on August 17, 2026 to shareholders of record as of July 24, 2026, with the ex-dividend date also falling on July 24, according to dividend data summarized by MarketBeat. On an annualized basis, this payout amounts to USD 4.35 per share, corresponding to a dividend yield of about 3.0% at a share price in the mid-140 dollar range.

The company’s dividend payout ratio is currently around 65.71%, based on the latest figures compiled by MarketBeat, indicating that roughly two-thirds of earnings are returned to shareholders in cash each year. While this is a substantial proportion, it still leaves meaningful room for reinvestment in brand building, product innovation and capacity, especially given Procter & Gamble’s stable earnings profile and long record of managing its capital allocation through economic cycles.

Risks from slow growth and consumer headwinds

Despite its income appeal, Procter & Gamble faces real challenges. Commentators on Seeking Alpha note that the company posted weak fiscal year 2026 results in organic terms, with only about 1% organic sales growth and similarly modest core EPS growth, and that management forecasts just 1% to 3% organic sales growth for fiscal year 2027. This slow-growth outlook reflects shifting consumer behavior, increased price sensitivity and competition from private-label brands, all of which can pressure volumes and limit the scope for further price increases.

For investors, the key risk is that low single-digit revenue growth may eventually constrain earnings expansion and justify the market’s willingness to pay only a moderate premium for the shares. In such an environment, multiple expansion is unlikely without a clear acceleration in organic growth or a notable improvement in margins. At the same time, the stock’s defensive characteristics and dependable dividend may cushion downside, but they do not eliminate the possibility of underperformance relative to faster-growing sectors when risk appetite in equity markets is high.

Representative product and brand reach

On the product side, a representative example of Procter & Gamble’s reach is its Tide laundry detergent brand, which sits within the Fabric & Home Care segment and contributes to the more than USD 87 billion in total revenue generated in fiscal year 2026, according to the company’s summarized performance figures cited by The Motley Fool. Tide and other core brands in categories such as diapers, grooming and household cleaning are central to the company’s strategy of maintaining shelf presence, pricing power and brand loyalty despite evolving consumer trends.

Stock level and market context

As of the latest trading indications reported on September 7, 2026, Procter & Gamble stock is quoted around USD 146.29 to USD 146.44 on the New York Stock Exchange, near the mid-point of its fifty-two week range between USD 137.62 and USD 167.25, with a market capitalization of roughly USD 339.78 billion according to MarketBeat. The share price has declined about 8% over the past twelve months, as noted by The Motley Fool, reflecting both sector-wide weakness in consumer staples and investor concerns about the company’s subdued organic growth trajectory.

For investors evaluating the stock at this level, the combination of a 3% dividend yield, low beta and a long history of reliable payouts must be weighed against modest growth and a valuation that already embeds a significant premium to many cyclical peers. Procter & Gamble’s defensive qualities remain intact, but future returns will likely depend on whether management can lift organic sales growth above the low single-digit range outlined for fiscal year 2027 and sustain margin resilience in a more demanding consumer landscape.

Procter & Gamble stock key data

  • Company: Procter & Gamble Company
  • ISIN: US7427181091
  • Ticker: PG
  • Trading venue: NYSE
  • Price (as of September 7, 2026): 146.44 USD
  • Market capitalization: 339.78 billion USD (as of September 7, 2026)
  • Sector / Industry: Consumer Staples / Household & Personal Products
  • Index membership: S&P 500

More news and analyses on Procter & Gamble stock

Disclaimer...

en | US7427181091 | PROCTER & GAMBLE CO. | boerse | 70063899 | bgmi